Overview
- Regulatory filings released in mid-September show Ellison adopted the trading plan on June 22 that would allow sales of up to 50 million shares through Oct. 24 under a Rule 10b5-1 schedule.
- The potential proceeds are roughly $7.5 billion at current prices, a scale that far exceeds Ellison’s usual, very small annual sales of Oracle stock.
- Even if he sells the full allotment, Ellison would still hold about 1.1–1.16 billion shares, keeping just over 40% ownership and maintaining control of the company.
- Recent disclosures indicate Ellison has pledged hundreds of millions of Oracle shares as collateral and given large personal guarantees for media financing, which may explain a need for extra liquidity.
- Market impact will depend on timing and mechanics because a 10b5-1 plan can execute gradually and may never trigger fully; investors are watching execution tempo as Oracle shares trade roughly 20% below this year’s highs near $150.